Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311497939> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4311497939 endingPage "S53" @default.
- W4311497939 startingPage "S53" @default.
- W4311497939 abstract "Bevacizumab, an effective targeted monoclonal antibody medication, has been approved for the treatment of metastatic colorectal cancer (mCRC) in Thailand since 2005. Bevacizumab is a high-cost drug that is currently accessible to only those who could afford its cost by themselves. Our study aims to evaluate the cost-utility of XELOX plus bevacizumab versus XELOX in mCRC treatment in Thailand." @default.
- W4311497939 created "2022-12-26" @default.
- W4311497939 creator A5022986629 @default.
- W4311497939 creator A5025479887 @default.
- W4311497939 creator A5055844394 @default.
- W4311497939 creator A5058993607 @default.
- W4311497939 creator A5059524529 @default.
- W4311497939 creator A5079881949 @default.
- W4311497939 date "2022-12-01" @default.
- W4311497939 modified "2023-09-26" @default.
- W4311497939 title "EE3 Cost-Utility Analysis of Xelox Plus Bevacizumab Versus Xelox for Metastatic Colorectal Cancer Treatment in Thailand" @default.
- W4311497939 doi "https://doi.org/10.1016/j.jval.2022.09.258" @default.
- W4311497939 hasPublicationYear "2022" @default.
- W4311497939 type Work @default.
- W4311497939 citedByCount "0" @default.
- W4311497939 crossrefType "journal-article" @default.
- W4311497939 hasAuthorship W4311497939A5022986629 @default.
- W4311497939 hasAuthorship W4311497939A5025479887 @default.
- W4311497939 hasAuthorship W4311497939A5055844394 @default.
- W4311497939 hasAuthorship W4311497939A5058993607 @default.
- W4311497939 hasAuthorship W4311497939A5059524529 @default.
- W4311497939 hasAuthorship W4311497939A5079881949 @default.
- W4311497939 hasConcept C121608353 @default.
- W4311497939 hasConcept C126322002 @default.
- W4311497939 hasConcept C143998085 @default.
- W4311497939 hasConcept C159654299 @default.
- W4311497939 hasConcept C203014093 @default.
- W4311497939 hasConcept C2776694085 @default.
- W4311497939 hasConcept C2777802072 @default.
- W4311497939 hasConcept C2777909004 @default.
- W4311497939 hasConcept C526805850 @default.
- W4311497939 hasConcept C542903549 @default.
- W4311497939 hasConcept C71924100 @default.
- W4311497939 hasConceptScore W4311497939C121608353 @default.
- W4311497939 hasConceptScore W4311497939C126322002 @default.
- W4311497939 hasConceptScore W4311497939C143998085 @default.
- W4311497939 hasConceptScore W4311497939C159654299 @default.
- W4311497939 hasConceptScore W4311497939C203014093 @default.
- W4311497939 hasConceptScore W4311497939C2776694085 @default.
- W4311497939 hasConceptScore W4311497939C2777802072 @default.
- W4311497939 hasConceptScore W4311497939C2777909004 @default.
- W4311497939 hasConceptScore W4311497939C526805850 @default.
- W4311497939 hasConceptScore W4311497939C542903549 @default.
- W4311497939 hasConceptScore W4311497939C71924100 @default.
- W4311497939 hasIssue "12" @default.
- W4311497939 hasLocation W43114979391 @default.
- W4311497939 hasOpenAccess W4311497939 @default.
- W4311497939 hasPrimaryLocation W43114979391 @default.
- W4311497939 hasRelatedWork W1965885537 @default.
- W4311497939 hasRelatedWork W1966121666 @default.
- W4311497939 hasRelatedWork W1997133872 @default.
- W4311497939 hasRelatedWork W2010928484 @default.
- W4311497939 hasRelatedWork W2037813108 @default.
- W4311497939 hasRelatedWork W2053918529 @default.
- W4311497939 hasRelatedWork W2145753255 @default.
- W4311497939 hasRelatedWork W2369149866 @default.
- W4311497939 hasRelatedWork W2587632802 @default.
- W4311497939 hasRelatedWork W349909140 @default.
- W4311497939 hasVolume "25" @default.
- W4311497939 isParatext "false" @default.
- W4311497939 isRetracted "false" @default.
- W4311497939 workType "article" @default.